U.S. federal trademark · Serial No. 50104124
Downloadable computer software for using artificial intelligence for the analysis, integration, modeling, prediction, and simulation of genomic, multiomic, and clinical data for use in drug discovery and development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, and clinical research concerning human health and diseases
Software as a service (SAAS) services featuring software using artificial intelligence (AI) for the analysis, integration, modeling, prediction, and simulation of genomic, multiomic, and clinical data for use in drug discovery and development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, and clinical research concerning human health and diseases; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for the analysis, integration, modeling, prediction, and simulation of genomic, multiomic, and clinical data for use in drug discovery and development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, and clinical research concerning human health and diseases; Scientific research and development; Scientific and technological services, namely, scientific research, analysis, integration, modeling, prediction, and simulation in the field of immunology, pharmaceuticals, drug discovery, drug development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, clinical research, and human health and diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.